Initial combination therapy with adalimumab and methotrexate leads to better long-term inhibition of radiographic progression in earl RA: 5-year results of the PREMIER trial

被引：0
|
作者：
van der Heijt, Desiree [1 ]
Landewe, Robert [1 ]
Shap, John T. [2 ]
Keystone, Edward C. [3 ]
Patra, Kaushik [4 ]
Perez, John L. [4 ]
Pangan, Aileen L. [5 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Abbott Labs, Parsippany, NJ USA
[5] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [21] Long-Term Benefits of the Spiration® Valve System in Emphysema Patients: 5-Year Results from the EMPROVE Trial
    Criner, G. J.
    Reed, M.
    Abu-Hijleh, M.
    Majid, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [22] Banded Gastric Bypass: Better Long-Term Results? A Cohort Study with Minimum 5-Year Follow-Up
    Lemmens, Luc
    OBESITY SURGERY, 2017, 27 (04) : 864 - 872
  • [23] Banded Gastric Bypass: Better Long-Term Results? A Cohort Study with Minimum 5-Year Follow-Up
    Luc Lemmens
    Obesity Surgery, 2017, 27 : 864 - 872
  • [24] Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial
    Rantalaiho, Vappu
    Kautiainen, Hannu
    Korpela, Markku
    Hannonen, Pekka
    Kaipiainen-Seppanen, Oili
    Mottonen, Timo
    Kauppi, Markku
    Karjalainen, Anna
    Laiho, Kari
    Laasonen, Leena
    Hakola, Mikko
    Peltomaa, Ritva
    Leirisalo-Repo, Marjatta
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (11) : 1954 - 1961
  • [25] Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ornbjerg, Lykke Midtboll
    Ejbjerg, Bo
    Hetland, Merete Lund
    Moller, Jakob Mollenbach
    Nielsen, Sabrina Mai
    Glinatsi, Daniel
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Christensen, Robin
    Ostergaard, Mikkel
    RMD OPEN, 2024, 10 (01):
  • [26] 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study
    Yamaguchi, Ayako
    Hirata, Shintaro
    Kubo, Satoshi
    Fukuyo, Shunsuke
    Hanami, Kentaro
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Saito, Kazuyoshi
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 799 - 806
  • [27] LONG-TERM THERAPY WITH GABAPENTIN (GBP NEURONTIN) - 5-YEAR EXPERIENCE FROM A US OPEN-LABEL TRIAL
    LEIDERMAN, DB
    KOTO, EM
    LAMOREAUX, LK
    MCLEAN, MJ
    EPILEPSIA, 1995, 36 : 345 - 345
  • [28] LONG-TERM DRUG-THERAPY OF MILD ARTERIAL-HYPERTENSION (RESULTS OF 5-YEAR FOLLOW-UP)
    ALMAZOV, VA
    BRODSKAYA, IS
    SHLYAKHTO, YV
    TERAPEVTICHESKII ARKHIV, 1992, 64 (09) : 94 - 97
  • [29] Abatacept (ABA) slows radiographic progression over 2 yrs in rheumatoid arthritis (RA) patients (Pts) with an inadequate response to methotrexate (MTX): Results from the long-term extension (LTE) of the AIM trial
    Westhovens, R.
    Peterfy, C.
    Vratsanos, G.
    Becker, J. C.
    Aranda, R.
    Teng, J.
    Kremer, J.
    Genant, H. K.
    RHEUMATOLOGY, 2007, 46 : I15 - I16
  • [30] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Phillip
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1455 - 1456
12345